Integrated Diagnostics Holdings plc (LON:IDHC)

Market Cap	294.52M
Revenue (ttm)	99.57M
Net Income (ttm)	16.15M
Shares Out	581.33M
EPS (ttm)	0.03
PE Ratio	17.82
Forward PE	14.94
Dividend	0.01 (2.52%)
Ex-Dividend Date	Sep 11, 2025

Volume	176,762
Average Volume	261,983
Open	0.6950
Previous Close	0.6800
Day's Range	0.6700 - 0.6950
52-Week Range	0.3050 - 0.7200
Beta	0.39
RSI	61.79
Earnings Date	Nov 13, 2025

About LON:IDHC

Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography, ultrasound, X-Ray, electromyography, electroencephalog...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1979
• Employees: 6,309
• Stock Exchange: London Stock Exchange
• Ticker Symbol: IDHC

Financial Performance

In 2024, LON:IDHC's revenue was 5.72 billion, an increase of 38.74% compared to the previous year's 4.12 billion. Earnings were 1.08 billion, an increase of 111.14%.

Financial numbers in EGP